Halozyme Therapeutics (HALO) – Analyst EPS Change
-
Halozyme Therapeutics (HALO) PT Raised to $24 at Deutsche Bank
-
Halozyme Therapeutics (HALO) PT Lowered to $20 at Citi on 'Very Poor PEGPH20 Pancreatic Cancer Data'
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to HALO Stock Lookup